CISPLATIN

Course overview

CISPLATIN IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF SOLID TUMORS AND HEMATOLOGIC MALIGNANCIES. IT IS IN THE ALKYLATING AGENT CLASS OF CYTOTOXIC MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CISPLATINUM AS A VALUABLE AGENT IN THE TREATMENT OF MALIGNANCY. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL ONCOLOGY TEAM IN THE CARE OF PATIENTS WITH MALIGNANCY TREATED WITH THIS AGENT.